| Financial Year |
March 31 2023 |
| Monetary Funds |
1,712,411,132.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,332,244.57 |
| Accounts Receivable |
1,286,922,368.55 |
| Advances to Suppliers |
17,190,455.86 |
| Other Receivables |
57,027,523.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
226,154,611.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
822,000.00 |
| Other Current Assets |
11,064,099.62 |
| Total Current Assets |
3,672,626,977.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
63,493,670.97 |
| Investment Properties |
-- |
| Fixed Assetes |
269,922,248.82 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
864,261,103.04 |
| R&D expenses |
86,668,757.97 |
| Goodwill |
93,960,012.11 |
| Long-Term Deferred and Prepaid Expenses |
2,325,086.27 |
| Deferred Income Tax Assets |
139,518,429.45 |
| Other Non-Current Assets |
119,089,355.79 |
| Sub-Total of Non-Current Assets |
2,309,789,215.15 |
| Total Assets |
5,982,416,192.73 |
| Short-Term Loans |
630,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
17,356,069.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
160,321,218.92 |
| Taxes Payable |
22,539,072.89 |
| Interest Payable |
-- |
| Dividend Payable |
4,728.47 |
| Other payables |
24,951,057.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,335,277.15 |
| Other Current Liabilities |
8,124,478.38 |
| Sub-Total of Current Liabilities |
986,198,542.24 |
| Long-term Loans |
-- |
| Bonds Payable |
838,425,126.63 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
100,842,307.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
945,950,785.33 |
| Total Liabilities |
1,932,149,327.57 |
| Paid-In Capital(Or Share Stock) |
874,755,827.00 |
| Capital Surplus |
845,427,708.28 |
| Surplus Reserve |
228,659,715.04 |
| LESS:Treasury Stock |
69,793,146.74 |
| Undistributed Profits |
1,990,422,046.22 |
| Minority Stockholder's Interest |
-884,744.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,051,151,609.27 |
| Owner's Equity（Stockholder's Equity） |
4,050,266,865.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,982,416,192.73 |
